Arcellx Inc (ACLX) stock news · rev $22.3M
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
This ACLX news page leads with what Arcellx Inc filed — not a scraped headline mill.
No cached 8-K sentence for ACLX yet. We will not pad this page with generic market recap.
Latest reported ACLX revenue for 2025-12-31 was $22.3M. Net income was -$228.9M. Revenue was down 79.4% from 2024-12-31 to 2025-12-31. ACLX currently screens at market cap $6.73B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ACLX stock page; for the tape open the quote page.
ACLX stock news FAQ
What are ACLX's latest revenue and net income?
Latest cached Arcellx Inc (ACLX) revenue for Dec 31, 2025 was $22.3M. Net income was -$228.9M. Statements: https://lician.com/financials/aclx
How did ACLX revenue change from the prior cached period?
Cached Arcellx Inc (ACLX) revenue was down 79.4% from $107.9M (Dec 31, 2024) to $22.3M (Dec 31, 2025). Statements: https://lician.com/financials/aclx
What is ACLX's market cap?
Arcellx Inc (ACLX) market cap is $6.73B on the latest cached fundamentals snapshot.
What kind of company is ACLX?
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Where is ACLX stock news listed?
Cached stock news for Arcellx Inc (ACLX) is listed at https://lician.com/news/aclx. Filings: https://lician.com/sec/aclx
Not investment advice.